by Anais MAX | Nov 8, 2021 | News
France Digitale unveils, on the occasion of France is AI, an exclusive mapping of 502 French startups specialized in artificial intelligence. SYNSIGHT is proud to share that we are one of those startups ! The mapping for 2021 shows the strong growth...
by Anais MAX | Sep 14, 2021 | News
Two days ago, Biolabs announced the six selected companies for their Masterclass program. SYNSIGHT founders will be participating in the 2021 Masterclass program organized by BioLabs and Servier ! A good chance to meet their team in Boston ! And in addition to being...
by Anais MAX | Sep 14, 2021 | Publications
Identification of a small molecule splicing inhibitor targeting UHM domains Abstract Splicing factor mutations are frequent in myeloid neoplasms, blood cancers and solid tumors. Cancer cells harboring these mutations present a particular vulnerability to drugs that...
by Anais MAX | Sep 7, 2021 | Publications
The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation Abstract TDP-43 is a nuclear RNA-binding protein that forms neuronal cytoplasmic inclusions in two major neurodegenerative diseases, ALS and FTLD. While the self-assembly of TDP-43...
by Anais MAX | Jun 10, 2021 | News
SYNSIGHT is selected in 2021 SPRING 50 selection, 50 most innovative and promising start-ups in the Paris-Saclay Innovation Playground ecosystem What is spring50 This is a selection that annually honors 50 start-ups from the Paris-Saclay cluster that are the most...